A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
Clinical trial NCT03239392 · COMPLETED
Trial details
- NCT number
- NCT03239392
- Sponsor
- Bioniz Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2020-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.